Garbuzova Evgeniia Vitalievna*, Shramko Victoria Sergeevna, Shakhtschneider Elena Vladimirovna and Ragino Yulia Igorevna Pages 1 - 20 ( 20 )
Adipocytokines secreted by adipokines can have both direct and indirect effects on the development of atherosclerosis progression. Research using modern high- -tech methods of molecular genetic analysis, which make it possible to identify the influence of certain variants of regulatory genes on the course of the atherosclerotic process, is becoming increasingly relevant. The review examines variants of genes (ADIPOQ, RETN, ITLN1, PBEF1, SCT, LEP, and GHRL) associated with obesity and metabolic disorders, as well as atherosclerosis-associated cardiovascular diseases. The review also addresses the mechanisms underlying various variants of visceral adipocytokine genes, as well as the translational potential of understanding these variants for therapeutic advances. The variants studied in the context of obesity, metabolic disorders, and atherosclerosis- associated cardiovascular diseases included rs1501299 (276G/T), rs2241766 (45G/T), rs74577862, rs182052, and rs266729 for ADIPOQ gene; rs1862513 (-420C/G), rs3745367 (299 G/A) for RETN gene; rs2274907 (326A/T) for ITLN1 gene; rs1319501 (G-948T), rs2302559, rs1215113036, rs11977021 (−3187G>A), rs4730153, and rs9770242 for PBEF1 gene; rs7799039 (G2548A), rs2167270 G>A, rs12112075 (G-2548A) for LEP gene; rs696217 (+408C>A, c.214G>T, p.Leu72Met), rs27647 (A-604G) for GHRL gene. The missense variant rs376423879 in the SCT gene was the only variant that has been studied in association with overweight. The contribution of gene variants to the development of obesity, metabolic disorders, and CVD depends on many factors, including lifestyle, nutrition, and other genetic and environmental factors. For a more accurate understanding of the role of the genes presented in the review, more research is needed in different populations, both in terms of the nature of the variation of genes predisposing to diseases associated with overweight, dyslipidemia, and atherosclerosis and in terms of the characteristics of their phenotypic manifestation.
Adipocyte, atherosclerosis-associated cardiovascular diseases, gene variants, obesity, metabolic disorders.